Remembering Kim MacIntosh

The Canadian Cancer Survivor Network would like to express our deepest sympathies to the family of Kimberly Ann MacIntosh, as she passed away in her home on November 17 at the age of 54. Kim was one of CCSN’s many advocates, sharing her Lung Cancer story particularly as part of the Right2Survive campaign. In her own words, Kim said, “To put it bluntly, I would

2021 Canadian Cancer Statistics Report Has Been Published

Earlier this month the Canadian Cancer Society published it’s annual Canadian Cancer Statistics Report. After a one year hiatus due to the COVID-19 pandemic, the report has been released in early November with many positive findings. The primary highlight in this year’s report reveals a 50% decline in the rate of prostate cancer deaths since its peak in 1995. Other key findings in the report

Dense Breasts Canada Publishes New Report On The Impacts of Outdated Breast Screening Practices

Dense Breasts Canada, an awareness and advocacy organization dedicated to seeing optimal breast cancer screening for women, has published a report outlining the findings of their latest national, anonymous, online survey that took place during the Summer of 2021. Over 2,500 people responded to their call and participated in the survey. All respondents were over the age of 20, and were proportionally distributed across Canadian

What Canadians Should Know About the Canadian National Breast Screening Studies

Update Oct. 8, 2021: To view this and all other webinars on demand visit our Webinars page   The Canadian Cancer Survivor Network is pleased to have Dr. Daniel Kopans from the Massachusetts General Hospital and Harvard Medical School present this webinar. In this session Dr. Kopans will discuss: The Canadian National Breast Screening Studies (CNBSS) are major outliers among the Randomized, Controlled Trials (RCT)

Protect our Access: Update on Changes to the Patent Medicines Pricing Review Board (PMPRB)

The federal government’s plan to push patented drug prices lower continues to meet with controversy. The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) have aroused criticism from patient groups and the pharmaceutical industry, which are concerned that the changes will result in fewer life-saving drugs being available in Canada. Rather than being open to dissenting voices and facilitating a constructive

Brain Tumour Incidence and Mortality Report

The Brain Tumour Registry of Canada (BTRC) published their Incidence and Mortality Report on May 26th, 2021. The detailed breakdown of the data and the inclusion of non-malignant tumours make this report uniquely valuable compared to other reporting on brain tumours.